ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Erasca Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
July 21, 2021Erasca, Inc. (Nasdaq: ERAS) today announced the closing of its initial public offering of 21,562,500 shares of common stock, which includes the exercise in full by the underwriters of their option to purchase 2,812,500 additional shares. -
Erasca picks up $42M to target biological drivers of cancer
December 25, 2018Erasca has raised a $42 million series A round from the likes of City Hill Ventures and Cormorant Asset Management to work toward the lofty goal to “not just treat, but actually cure cancer.” ....
Pharma Sources Insight January 2025
